» Authors » G F Strippoli

G F Strippoli

Explore the profile of G F Strippoli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 87
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiggins K, Craig J, Johnson D, Strippoli G
Cochrane Database Syst Rev . 2008 Feb; (1):CD005284. PMID: 18254075
Background: Peritonitis is a common complication of peritoneal dialysis (PD) and is associated with significant morbidity. Adequate treatment is essential to reduce morbidity and recurrence. Objectives: To evaluate the benefits...
2.
Palmer S, Nand K, Strippoli G
Cochrane Database Syst Rev . 2008 Feb; (1):CD001537. PMID: 18253993
Background: Steroids have been used widely since the early 1970s for the treatment of adult-onset minimal change disease. The response rates to immunosuppressive agents in adult minimal change disease, especially...
3.
Palmer S, McGregor D, Strippoli G
Cochrane Database Syst Rev . 2007 Jul; (3):CD005015. PMID: 17636784
Background: Patients with chronic kidney disease have significant abnormalities of bone remodeling and mineral homeostasis and are at increased risk of fracture. The fracture risk for a kidney transplant recipient...
4.
Rabindranath K, Strippoli G, Daly C, Roderick P, Wallace S, MacLeod A
Cochrane Database Syst Rev . 2006 Oct; (4):CD006258. PMID: 17054289
Background: Renal replacement therapy (RRT) for end-stage kidney disease (ESKD) can be achieved by several interventions including haemodialysis (HD), peritoneal dialysis (PD) and kidney transplantation. HD, haemofiltration (HF), haemodiafiltration (HDF)...
5.
Strippoli G, Hodson E, Jones C, Craig J
Cochrane Database Syst Rev . 2006 Jan; (1):CD005133. PMID: 16437521
Background: Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid organ transplant recipients. Pre-emptive treatment with antiviral agents of patients with CMV viraemia has been widely adopted...
6.
Strippoli G, Manno C, Schena F, Craig J
Cochrane Database Syst Rev . 2003 Jan; (1):CD003967. PMID: 12535495
Background: Anaemia affects 60-80% of patients with renal impairment, reduces quality of life and is a risk factor for early death. Treatment options are blood transfusion, erythropoietin (EPO) alpha or...
7.
Schena F, Strippoli G, Wankelmuth P
Am J Nephrol . 1999 Apr; 19(2):308-12. PMID: 10213833
It is known that a series of mediators, so-called growth factors, are able to induce hypertrophy of the kidney in a patient after uninephrectomy. The first investigator who demonstrated this...